Where does Bio-techne Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bio-techne Corporation ranks #22,276 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bio-techne Corporation hold?

Bio-techne Corporation holds 12 US utility patents granted between 2016 and 2024, spanning 8 technology areas.

What is Bio-techne Corporation's Innovation Score?

Bio-techne Corporation has an Innovation Score of 33.0 out of 100 (43rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bio-techne Corporation focus on?

Bio-techne Corporation's top technology area is C07K (Peptides) with 6 patents, ranking #1,362 of 3,615 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Bio-techne Corporation's patent grant rate increasing or decreasing?

Bio-techne Corporation's recent grant velocity is +400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Bio-techne Corporation's patents?

Bio-techne Corporation's patents average 16.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bio-techne Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Bio-techne Corporation

USPTO PatentsView assignee record - 12 granted patents across 8 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bio-techne ranks #22,276 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 8 technology areas.

#22,276
of 49,997 US assignees by volume: 43rd percentile
by Innovation Score (33.0/100): 16.1
avg claims per patent: +400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22276 · US Corporation #22,276 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #22,276/49,997
PHOTO-FINISH Bernina International
CPC-NARROW C07K · 8 areas
INNOV-THIN 33.0/100
CLAIMS-RICH 16.1 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bernina International AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bio-techne’s 33.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (27%) Velocity 4.4 pts (13%) Breadth 10.0 pts (30%) Claim depth 9.6 pts (29%)

Qualcomm Incorporated · highest

85
Bio-techne · this assignee

33
3D Lighting… · lowest

7

What this shows Bio-techne's Innovation Score is 33.0/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Bio-techne?

Each dot is one of Bio-techne’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bio-techne’s own 16.1 claims/patent is ABOVE the 12.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Bio-techne vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bio-techne's grants concentrate

Bio-techne Corporation is a focused PatentsView assignee: 8 CPC subclasses with 50% of grants classified under C07K (Peptides). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2022. By volume, Bio-techne sits between Bernina International AG and Biotheranostics, Inc..

Bio-techne's three-year grant acceleration

Bio-techne Corporation shows 4 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Bernina Internati…

12
Bessey Tool & KG

12
Beumer Group A/S

12
BGP China Nationa…

12
Bioasis

12
Bion

12
Biotechnology Ins…

12
Biotheranostics

12
Bio-techne ◀

12

What this shows Bio-techne holds 12 patents at rank #22,256, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bio-techne

By rank, the assignees closest to #22,256 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Bio-techne's primary technology class.

Bio-techne's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 43rd percentile higher than 43% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Bio-techne Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	16.7%
2020	3	25.0%
2021	3	25.0%
2022	1	8.3%
2023	2	16.7%
2024	1	8.3%

Which technologies does Bio-techne Corporation patent most?

C07K - Peptides 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 2

C12Y - Enzymes 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Bio-techne Corporation's patent record in context - here's where to go next.

Bio-techne Corporation's lead technology class is C07K (Peptides), 50% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #22,276 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bio-techne Corporation against Bernina International AG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.